Collaboration delivers strategic Neurodiversity initiatives, with comprehensive support and advanced analytics and insights tailored to both individual and organizational needs....
Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription...
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a...
RESTON, Va., Jan. 6, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced that its wholly owned subsidiary, QTC Medical Services, operating under the...
MIAMI, FL, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”),...
VYVDURA® now approved for at-home self-injection in Japan for both generalized myasthenia gravis and CIDP argenx's VYVGART® and VYVDURA portfolio...
Leland to discuss his best-selling book, “The Country of the Blind: A Memoir at the End of Sight” LOS ANGELES,...
Dravet syndrome is a genetic developmental and epileptic encephalopathy (DEE) often caused by a mutation in SCN1A This is the...
Hoesman, Access Living to Advance Inclusion for 'Nation's Largest Minority Group' CHICAGO, Dec. 17, 2024 /PRNewswire/ -- Scott Hoesman, CEO and...
Secondary analysis of a randomized, placebo-controlled study of 1,000+ participants indicated that FDA-authorized RelieVRx® yielded clinically meaningful pain intensity and pain...
Groundbreaking thinkALS™ Tool Empowers Providers to Identify and Refer Patients Quicker ARLINGTON, Va., Dec. 10, 2024 /PRNewswire/ -- It can take...
Collaboration Focuses on Streamlining VA Disability Claims, Expanding Veteran Support Services, and Enhancing Resources AUSTIN, Texas, Dec. 4, 2024 /PRNewswire/...
Redefining Advocacy for the Injured and The Unsettling Truth About SettlingTORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- In an effort...
Focused Ultrasound Therapy for tremors is now available for patients with Dr. Taghva in Orange County MISSION VIEJO, CAPELLEN /...
Nes-Ziona, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
The sNDA submission is based on positive results from Studies 501 and 502 demonstrating CAPLYTA’s robust antidepressant efficacy and favorable...
HO CHI MINH CITY, Vietnam, Nov. 29, 2024 /PRNewswire/ -- After several years of intensive investment in R&D, TMA Solutions launched...
Two top healthcare awards underline Brainomix's landmark achievements in 2024 and the validation of its software's impact on treatment ratesOXFORD,...
TORONTO, ON / ACCESSWIRE / November 27, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ")...